CDK3/CycO Recombinant humaan actief eiwit Kinase

CDK3 is a major player driving retinoblastoma (Rb) phosphorylation during the G0/G1 transition and in the early G1 phase of the cell cycle. CDK3 interacts with various transcription factors involved in cell proliferation, differentiation, and transformation driven by the EGFR/Ras signaling pathway. CDK3/CycO Recombinant Human Active Protein Kinase is an ortholog of CDK3[1].

12352211

CDK

Cell Cycle/DNA Damage

Cancer

[CDK3/CycORecombinantHumanActiveProteinKinase]

[1]Teo T, et al. An overview of CDK3 in cancer: clinical significance and pharmacological implications. Pharmacol Res. 2022 Jun;180:106249.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-E70680/

Enzyme

No Development Reported